These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28945163)

  • 21. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost differential by site of service for cancer patients receiving chemotherapy.
    Hayes J; Hoverman RJ; Brow ME; Dilbeck DC; Verrilli DK; Garey J; Espirito JL; Cardona J; Beveridge R
    Am J Manag Care; 2015 Mar; 21(3):e189-96. PubMed ID: 26014306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost perspectives for outpatient intravenous antimicrobial therapy.
    Tice AD; Hoaglund PA; Nolet B; McKinnon PS; Mozaffari E
    Pharmacotherapy; 2002 Feb; 22(2 Pt 2):63S-70S. PubMed ID: 11837549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional variation in the cost of infrainguinal lower extremity bypass surgery in the United States.
    Nejim BJ; Wang S; Arhuidese I; Obeid T; Alshaikh HN; Dakour Aridi H; Locham S; Malas MB
    J Vasc Surg; 2018 Apr; 67(4):1170-1180.e4. PubMed ID: 29074114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality.
    Vera-Llonch M; Weycker D; Glass A; Gao S; Borker R; Qin A; Oster G
    BMC Cancer; 2011 Jun; 11():250. PubMed ID: 21676243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study.
    DaCosta Byfield S; Buck PO; Blauer-Peterson C; Poston SA; DaCosta Byfield S; Buck PO; Blauer-Peterson C; Poston SA
    J Oncol Pract; 2016 Feb; 12(2):159-67. PubMed ID: 26395563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients.
    Gilden DM; Kubisiak JM; Pohl GM; Ball DE; Gilden DE; John WJ; Wetmore S; Winfree KB
    J Med Econ; 2017 Feb; 20(2):151-161. PubMed ID: 27574722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Contemporary Medicolegal Analysis of Outpatient Medication Management in Chronic Pain.
    Abrecht CR; Brovman EY; Greenberg P; Song E; Rathmell JP; Urman RD
    Anesth Analg; 2017 Nov; 125(5):1761-1768. PubMed ID: 29049120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
    Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive care unit admission after endovascular aortic aneurysm repair is primarily determined by hospital factors, adds significant cost, and is often unnecessary.
    Hicks CW; Alshaikh HN; Zarkowsky D; Bostock IC; Nejim B; Malas MB
    J Vasc Surg; 2018 Apr; 67(4):1091-1101.e4. PubMed ID: 29074117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States.
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2019 Jun; 39(6):3137-3140. PubMed ID: 31177159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
    Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
    J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting.
    Shah M; Winfree KB; Peterson P; Gruschkus SK; Eaddy M; Green MR
    Lung Cancer; 2013 Oct; 82(1):121-7. PubMed ID: 23973203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer.
    Wright JD; Hou JY; Burke WM; Tergas AI; Chen L; Hu JC; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2016 Jun; 127(6):985-991. PubMed ID: 27159764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
    Bennett CL; Calhoun EA
    Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments.
    Wittayanukorn S; Qian J; Westrick SC; Billor N; Johnson B; Hansen RA
    Res Social Adm Pharm; 2015; 11(5):708-20. PubMed ID: 25582892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting.
    Lipitz-Snyderman A; Atoria CL; Schleicher SM; Bach PB; Panageas KS
    J Oncol Pract; 2019 Jan; 15(1):e30-e38. PubMed ID: 30543762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time and labor costs associated with administration of intravenous bisphosphonates for breast or prostate cancer patients with metastatic bone disease: a time and motion study.
    Xie F; Hopkins RB; Burke N; Habib M; Angelis CD; Pasetka M; Giotis A; Goeree R
    Hosp Pract (1995); 2014 Apr; 42(2):38-45. PubMed ID: 24769783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.